Cargando…

NIMH funding opportunities for NeuroAIDS therapeutics development research

Detalles Bibliográficos
Autores principales:	Bao, Jing, Kopnisky, Kathy
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716896/ http://dx.doi.org/10.1186/1742-4690-3-S1-P72

Ejemplares similares

Contribution of CNS cells in NeuroAIDS
por: Verma, Ashish Swarup, et al.
Publicado: (2010)

Opiate Drug Use and the Pathophysiology of NeuroAIDS
por: Hauser, Kurt F, et al.
Publicado: (2012)

Role of Biosensing Technology for NeuroAIDS Management
por: Jayant, RD, et al.
Publicado: (2016)

Advancing research in NeuroAIDS using collaboration and public data sharing
por: Cysique, Lucette A.
Publicado: (2015)

Multifunctional Nanotherapeutics for the Treatment of neuroAIDS in Drug Abusers
por: Jayant, Rahul Dev, et al.
Publicado: (2018)

Molecular epigenetics, chromatin, and NeuroAIDS/HIV: Translational implications
por: Shapshak, Paul, et al.
Publicado: (2008)

Molecular epigenetics, chromatin, and NeuroAIDS/HIV: Immunopathological implications
por: Chiappelli, Francesco, et al.
Publicado: (2008)

Sustained-release nanoART formulation for the treatment of neuroAIDS
por: Jayant, Rahul Dev, et al.
Publicado: (2015)

Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS
por: Sarma, Anupam, et al.
Publicado: (2020)

The integrated National NeuroAIDS Tissue Consortium database: a rich platform for neuroHIV research
por: Heithoff, Abigail J, et al.
Publicado: (2019)

When do models of NeuroAIDS faithfully imitate “the real thing”?
por: Gelman, Benjamin B., et al.
Publicado: (2017)

HIV-Tat regulates macrophage gene expression in the context of neuroAIDS
por: Carvallo, Loreto, et al.
Publicado: (2017)

Proceedings of the ISEV symposium on “HIV, NeuroAIDS, drug abuse & EVs”
por: Hu, Guoku, et al.
Publicado: (2017)

Advances in SIV/SHIV Non-Human Primate Models of NeuroAIDS
por: Moretti, Sonia, et al.
Publicado: (2021)

Planning Future Strategies for Domestic and International NeuroAIDS Research, July 24–25, 2008
por: Joseph, Jeymohan, et al.
Publicado: (2009)

Minocycline Inhibition of Monocyte Activation Correlates with Neuronal Protection in SIV NeuroAIDS
por: Campbell, Jennifer H., et al.
Publicado: (2011)

Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuse
por: Sagar, Vidya, et al.
Publicado: (2016)

A SIV molecular clone that targets the CNS and induces neuroAIDS in rhesus macaques
por: Matsuda, Kenta, et al.
Publicado: (2017)

Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS
por: Sagar, Vidya, et al.
Publicado: (2017)

The National NeuroAIDS Tissue Consortium (NNTC) Database: an integrated database for HIV-related studies
por: Cserhati, Matyas F., et al.
Publicado: (2015)

Interactive effects of cocaine on HIV infection: implication in HIV-associated neurocognitive disorder and neuroAIDS
por: Dahal, Santosh, et al.
Publicado: (2015)

HIV-tat alters Connexin43 expression and trafficking in human astrocytes: role in NeuroAIDS
por: Berman, Joan W., et al.
Publicado: (2016)

Temporal/compartmental changes in viral RNA and neuronal injury in a primate model of NeuroAIDS
por: González, R. Gilberto, et al.
Publicado: (2018)

Monocytes-Derived Macrophages Mediated Stable Expression of Human Brain-Derived Neurotrophic Factor, a Novel Therapeutic Strategy for NeuroAIDS
por: Tong, Jing, et al.
Publicado: (2014)

Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats
por: Repunte-Canonigo, Vez, et al.
Publicado: (2014)

Boosting the Brain Delivery of Atazanavir through Nanostructured Lipid Carrier-Based Approach for Mitigating NeuroAIDS
por: Khan, Saif Ahmad, et al.
Publicado: (2020)

A prospective longitudinal in vivo (1)H MR spectroscopy study of the SIV/macaque model of neuroAIDS
por: Fuller, Robert A, et al.
Publicado: (2004)

The National NeuroAIDS Tissue Consortium Brain Gene Array: Two Types of HIV-Associated Neurocognitive Impairment
por: Gelman, Benjamin B., et al.
Publicado: (2012)

Clathrin-nanoparticles deliver BDNF to hippocampus and enhance neurogenesis, synaptogenesis and cognition in HIV/neuroAIDS mouse model
por: Vitaliano, Gordana D., et al.
Publicado: (2022)

The Use of NeuroAiD (MLC601) in Postischemic Stroke Patients
por: Navarro, Jose C., et al.
Publicado: (2012)

Safety and Use of MLC601/MLC901 (NeuroAiD(TM)) in Primary Intracerebral Hemorrhage: A Cohort Study from the NeuroAiD Safe Treatment Registry
por: Kumar, Ramesh, et al.
Publicado: (2020)

Proton Magnetic Resonance Spectroscopy Reveals Neuroprotection by Oral Minocycline in a Nonhuman Primate Model of Accelerated NeuroAIDS
por: Ratai, Eva-Maria, et al.
Publicado: (2010)

The NeuroAiD Safe Treatment (NeST) Registry: a protocol
por: Venketasubramanian, Narayanaswamy, et al.
Publicado: (2015)

Computational psychiatry: a report from the 2017 NIMH workshop on opportunities and challenges
por: Ferrante, Michele, et al.
Publicado: (2018)

Lentiviral vector-mediated stable expression of sTNFR-Fc in human macrophage and neuronal cells as a potential therapy for neuroAIDS
por: Cao, Shengbo, et al.
Publicado: (2011)

Effects of morphine and NeuroAid on the expression levels of GluN2A and GluN3A in the hippocampus and striatum of rats
por: Heshmatzad, Katayoun, et al.
Publicado: (2021)

The NIMH global mental health research community and COVID-19
por: Rahman, Atif, et al.
Publicado: (2020)

Ischemic Stroke and Savings in Time to Achieve Functional Recovery: Experience from NeuroAiD
por: Venketasubramanian, Narayanaswamy, et al.
Publicado: (2023)

A decade of investment, HIV prevention research and development funding from 2000 through 2011
por: Fisher, K, et al.
Publicado: (2012)

Saving time and money: a validation of the self ratings on the prospective NIMH life-chart method (NIMH-LCM)
por: Born, Christoph, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_52ucsommg2jo47pu7h62jaotl9